WO2009025094A1 - Procédé de diagnostic d'un cancer chez un mammifère - Google Patents

Procédé de diagnostic d'un cancer chez un mammifère Download PDF

Info

Publication number
WO2009025094A1
WO2009025094A1 PCT/JP2008/050717 JP2008050717W WO2009025094A1 WO 2009025094 A1 WO2009025094 A1 WO 2009025094A1 JP 2008050717 W JP2008050717 W JP 2008050717W WO 2009025094 A1 WO2009025094 A1 WO 2009025094A1
Authority
WO
WIPO (PCT)
Prior art keywords
mammal
diagnosing cancer
midkine
optimizing
plasma
Prior art date
Application number
PCT/JP2008/050717
Other languages
English (en)
Japanese (ja)
Inventor
Tsuneya Ohno
Original Assignee
Tsuneya Ohno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsuneya Ohno filed Critical Tsuneya Ohno
Priority to JP2009528961A priority Critical patent/JPWO2009025094A1/ja
Publication of WO2009025094A1 publication Critical patent/WO2009025094A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention vise à proposer un procédé pour diagnostiquer un cancer chez un mammifère. L'invention porte sur un procédé consistant à mesurer la concentration en midkine dans le sang, en particulier, dans le plasma d'un mammifère portant une tumeur maligne en optimisant la combinaison d'anticorps employés.
PCT/JP2008/050717 2007-08-20 2008-01-21 Procédé de diagnostic d'un cancer chez un mammifère WO2009025094A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009528961A JPWO2009025094A1 (ja) 2007-08-20 2008-01-21 哺乳動物の癌の診断方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007213271 2007-08-20
JP2007-213271 2007-08-20

Publications (1)

Publication Number Publication Date
WO2009025094A1 true WO2009025094A1 (fr) 2009-02-26

Family

ID=40378003

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/050717 WO2009025094A1 (fr) 2007-08-20 2008-01-21 Procédé de diagnostic d'un cancer chez un mammifère

Country Status (2)

Country Link
JP (1) JPWO2009025094A1 (fr)
WO (1) WO2009025094A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001020333A1 (fr) * 1999-09-10 2001-03-22 Meiji Milk Prod Co Ltd Marqueur de tumeur pour les cancers a un stade precoce

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001020333A1 (fr) * 1999-09-10 2001-03-22 Meiji Milk Prod Co Ltd Marqueur de tumeur pour les cancers a un stade precoce

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
AKIO HIRAMA ET AL.: "Saishin no chiryo guideline kankohensho", DOYAKUSHI, vol. 23, no. 5, 1 May 2006 (2006-05-01), pages 14 - 21 *
FU CHONG ET AL.: "Cloning and sequence of the xenopus laevis homologue of the midkine cDNA", GENE, vol. 146, no. 2, 2 September 1994 (1994-09-02), pages 311 - 312 *
MAMORU KONUMA: "Lymphoma no shindan to chiryo", VEC, vol. 4, no. 4, 1 December 2006 (2006-12-01), pages 18 - 36 *
MOTOJI KITAWAGA ET AL.: "Kensa data o kangaeru suigan", KENSA TO GIJUTSU, vol. 31, no. 1, 1 January 2003 (2003-01-01), pages 65 - 69 *
SATOSHI SAITO: "Kan saibogan no saihatsu to saihatsu yobo", THE JOURNAL OF MEDICINE, vol. 50, no. 1, 25 July 2003 (2003-07-25), pages 71 - 75 *
SHUNTARO IKEDA ET AL.: "Ushi midkine(MK) no cDNA cloning to ushi ranshi saiboshitsu seijuku sokushin inshi to shite no kumikae tanpakushitsu no sakusei", SHOKUNIKU NI KANSURU JOSEI KENKYU CHOSA SEIKA HOKOKUSHO, vol. 18, December 2000 (2000-12-01), pages 21 - 26 *
TAKEHITO YAMAGUCHI: "Suigan soki shindan no strategy suigan soki shindan no tame no shindan taikei no arikata", RINSHO SHOKAKI NAIKA, vol. 21, no. 13, 20 November 2006 (2006-11-20), pages 1717 - 1723 *
TSUJIMURA A. ET AL.: "Developmental and defferential regulations in gene expression of xenopus pleiotrophic factors-alpha and -beta", BIOCHEM.BIOPHYS.RES.COMMUN., vol. 214, no. 2, 14 September 1995 (1995-09-14), pages 432 - 439 *
YOSHINORI OISHI ET AL.: "Neko no kojosen gan no ichirei", THE JAPANESE SOCIETY OF SMALL ANIMAL VETERINARY MEDICINE SHOROKU, vol. 2004, 2004, pages 17 *
YOSHIYUKI KOBAYASHI ET AL.: "Kanzogan no rinsho kensa kanzogan shindan eno approach", CLINICAL TESTING, vol. 49, no. 11, 15 November 2005 (2005-11-15), pages 1201 - 1205 *

Also Published As

Publication number Publication date
JPWO2009025094A1 (ja) 2010-11-18

Similar Documents

Publication Publication Date Title
NZ598194A (en) Anti-cmet antibody and its use for the detection and the diagnosis of cancer
WO2007082144A3 (fr) Methode permettant de detecter un cancer a l'aide de b7-h1 et de survivine
WO2011143361A3 (fr) Méthodes et compositions utilisées dans le cadre du diagnostic de maladies
EP1922326A4 (fr) Biomarqueurs utiles pour diagnostiquer un cancer de la prostate et procédé d'utilisation de ceux-ci
WO2007109376A3 (fr) Thérapeutique anticorps antigène de cellules anti-tumorales
MX340453B (es) Biomarcadores para cancer de pulmon.
WO2010099342A3 (fr) Procédés de détection du cancer du poumon
WO2010129934A3 (fr) Méthodes et compositions pour le diagnostic d'affections thyroïdiennes
WO2010135692A3 (fr) Biomarqueurs miarn d'une maladie prostatique
WO2008008284A3 (fr) Biomarqueurs du cancer et méthodes d'utilisation
WO2011045080A3 (fr) Anticorps monoclonaux contre la progastrine et leurs utilisations
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
NZ610592A (en) Anti-il-23 antibodies
WO2010009337A3 (fr) Signatures et déterminants de la pc associés au cancer de la prostate et leurs procédés d’utilisation
WO2013066369A3 (fr) Procédés de détection de maladie du greffon contre l'hôte
WO2010009171A3 (fr) Activation de src pour déterminer le pronostic du cancer et en tant que cible pour la thérapie du cancer
NZ616382A (en) Antibodies specific to cadherin-17
WO2011112845A3 (fr) Méthodes et compositions associés à un essai de méthylation multiple pour prédire l'évolution de l'état de santé d'un patient
WO2011074802A3 (fr) Kit pour diagnostic du cancer de la prostate et méthode de diagnostic
WO2012082742A3 (fr) Détection du cancer par des anticorps anti-ccl25 et anti-ccr9
EP2275809A4 (fr) Procédé de diagnostic du cancer du pancréas à l aide de chaînes de sucre de type à liaison n
WO2012018877A9 (fr) Traitement du cancer du sein avec un anticorps anti-il-19
WO2009003082A3 (fr) Compositions immunologiques utilisées en tant que biomarqueurs et/ou agents thérapeutiques pour le cancer
WO2012059750A3 (fr) Facteurs
WO2012145399A3 (fr) Procédés de diagnostic d'un cancer chez un patient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08703567

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009528961

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08703567

Country of ref document: EP

Kind code of ref document: A1